Ninian N Lang, David E Newby. Show Affiliations »
Abstract
Mesh: See more » AnimalsAntineoplastic Agents/administration & dosageAntineoplastic Agents/pharmacologyCell Proliferation/drug effectsCoronary Restenosis/prevention & controlCoronary Stenosis/therapyCoronary Thrombosis/etiologyCoronary Thrombosis/geneticsCoronary Thrombosis/metabolismCoronary Thrombosis/physiopathologyDrug Delivery SystemsEndothelium, Vascular/drug effectsEndothelium, Vascular/pathologyHumansMiceMice, TransgenicPaclitaxel/administration & dosagePaclitaxel/pharmacologyPlasminogen Activator Inhibitor 1/geneticsPlasminogen Activator Inhibitor 1/metabolismRNA, Messenger/geneticsRNA, Messenger/metabolismRisk FactorsSirolimus/administration & dosageSirolimus/pharmacologyStents/adverse effectsTissue Plasminogen Activator/geneticsTissue Plasminogen Activator/metabolismUp-Regulation/genetics
Substances: See more » Antineoplastic AgentsPlasminogen Activator Inhibitor 1RNA, MessengerTissue Plasminogen ActivatorPaclitaxelSirolimus
Year: 2007 PMID: 17229968 DOI: 10.1161/01.ATV.0000255308.41576.ae
Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN: 1079-5642 Impact factor: 8.311